Varicella Clinical Trials

3 recruiting

Varicella Trials at a Glance

7 actively recruiting trials for varicella are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Phase 3 with 2 trials, with the heaviest enrollment activity in Akdeniz, Ankara, and Ansan. Lead sponsors running varicella studies include Association Clinique Thérapeutique Infantile du val de Marne, GC Biopharma Corp, and Assistance Publique - Hôpitaux de Paris.

Browse varicella trials by phase

About Varicella Clinical Trials

Looking for clinical trials for Varicella? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Varicella trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Varicella clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 3

A Study to Evaluate Immunogenicity and Safety After the First and Second Doses of MG1111 (BARYCELA Inj.) in Healthy Children Aged 12 Months to 12 Years

Varicella (Chickenpox)Chickenpox Vaccine
GC Biopharma Corp474 enrolled1 locationNCT07054099
Recruiting
Phase 3

Second Dose of Varicella Vaccine in Healthy Children

Varicella (Chickenpox)Varicella Immunisation
Sinovac (Dalian) Vaccine Technology Co., Ltd.300 enrolled5 locationsNCT07475000
Recruiting

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Streptococcus PneumoniaeMalariaMeningitis+55 more
Institut Pasteur du Cambodge10,000 enrolled1 locationNCT07358910
Recruiting

Evaluation of the Anti-VZV Vaccine Response of Patients With Immune-mediated Systemic Inflammatory Diseases Vaccinated in the Care Setting

Vaccination Varicella-zoster VirusImmune-mediated Systemic Inflammatory Diseases
Assistance Publique - Hôpitaux de Paris50 enrolled1 locationNCT07047053
Recruiting

Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric Patients

OncologyTransplantation InfectionHerpesviridae Infections+2 more
University of Pisa200 enrolled1 locationNCT05198570
Recruiting

Pediatric and Ambulatory Research in Infectious Diseases

PharyngitisPneumoniaVaricella+3 more
Association Clinique Thérapeutique Infantile du val de Marne400,000 enrolled1 locationNCT04471493
Recruiting
Phase 2

Evaluate the Safety and Immunogenicity After MG1111(BARICELA Inj.) as 2nd Vaccination in 4 ~ 6 Year Old Healthy Children With a History of 1st Varicella Vaccination

Varicella
Green Cross Corporation230 enrolled1 locationNCT05422508